Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen.

Xiao, XiaoFang; Ye, XingNong; Xu, Cheng; Huang, Jian

Xiao, XiaoFang; Ye, XingNong; Xu, Cheng; Huang, Jian.

Afiliação

Xiao X; Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China, househuang@zju.edu.cn.
Ye X; Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China, househuang@zju.edu.cn.
Xu C; Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China, househuang@zju.edu.cn.
Huang J; Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China, househuang@zju.edu.cn.

Onco Targets Ther ; 11: 7555-7558, 2018.

Article em En | MEDLINE | ID: mdl-30464503

Palavras-chave

DC-CIK; acute lymphoblastic leukemia; relapsed; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google